Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
Dr. Gibson joining Lexaria's new scientific advisor board KELOWNA, BC / ACCESSWIRE / December 17, 2024 / Lexaria Bioscience Corp....
Brain
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,...
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.GUILFORD,...
Vaccinex Announces Receipt of Delisting Notification from Nasdaq
ROCHESTER, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company...
NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025
Company’s Exclusive Distribution Agreement with Zimmer Biomet included $3.0 Million Upfront Payment: Expected to Drive Revenue and Expand Margins Significantly...
Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review...
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium
Single intrathecal dose of Rhenium (186Re) Obisbemeda delivers favorable responses in cerebrospinal fluid circulating tumor cell count, imaging, and clinical...
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
Exploring Space and Neurotherapeutics at the 2025 Ultrasound Event: A Journey into the Future of Medical Ultrasound
ORLANDO, Fla., Dec. 16, 2024 /PRNewswire/ -- The 2025 AIUM Annual Convention, hosted by the American Institute of Ultrasound in...
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial
Clinical Trial Demonstrates Superior Metabolic Control During Prolonged Fasting in PKU PatientsResults Expected to Promote Awareness and Adoption of PKU...
How Popular Weight Loss Drugs Are Reshaping Holiday Feasts
Dr. Michael Koehler, Medical Director at Affinity Whole Health, offers tips ahead of the holiday season. VALLEY VIEW, OH /...
Yale Neurosurgeon Dr. Patrick F. Doherty: Where Surgical Excellence Meets Compassionate Care
A Profile of Innovation and Patient-Centered Neurosurgery at Yale Medicine NEW HAVEN, CONNECTICUT / ACCESSWIRE / December 13, 2024 /...
Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast Cancer Symposium (SABCS)
Single-agent MDNA11 was more effective than a combination of immune checkpoint inhibitors (anti-mPD1 and anti-mCTLA4) in preventing metastasis and achieving...
SOUP AI Platform Launches Crowdfunding Campaign
Charlotte, North Carolina--(Newsfile Corp. - December 12, 2024) - SOUP, the first fully AI-driven social platform, transforming idea-sharing and collaboration,...
Healthcare Executives Embrace Generative AI to Boost Patient Outcomes
Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Dec. 12, 2024 /PRNewswire/ -- USA News Group News Commentary – The...
Cellev8 Nutrition Launches the First GLP1 Support Gummy With Clinically Tested Ingredients
CELLEV8 Launches First Post-GLP-1 Gummy Supplement: "SlimCell™" with Clinically Proven Ingredients to Compliment GLP-1 WELLINGTON, FL / ACCESSWIRE / December...
iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress
- Inupadenant + carboplatin/pemetrexed in Phase 2 A2A-005 trial demonstrated a 63.9% overall response rate (ORR) and a median PFS...
BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
2024 Design Intelligence Award Held at China Academy of Art, Hangzhou, China
HANGZHOU, China, Dec. 12, 2024 /PRNewswire/ -- The ceremony for the 2024 Design Intelligence Award (DIA) took place on December...
Medical Gas Blenders Market to Grow by USD 582 Million (2024-2028), Driven by Aging Population and Chronic Diseases, with AI Impacting Market Trends – Technavio
NEW YORK, Dec. 11, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global medical gas blenders...